Rare diseases
Investigational molecules
Locations
1205 Johnson Ferry Road Suite 136 # 518, 30068-5401, United States
Airway Therapeutics Inc. concentrates its research efforts on developing innovative treatments for severe respiratory conditions and lung diseases. The company's clinical investigation portfolio demonstrates a commitment to addressing critical pulmonary pathologies that significantly impact patient quality of life and survival outcomes.
The sponsor's therapeutic development programs focus on novel approaches to restore and maintain airway function, targeting both acute exacerbations and chronic progressive respiratory disorders through specialized biological interventions.
Airway Therapeutics Inc. runs clinical trials in conditions such as Bronchopulmonary dysplasia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
